http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56169676-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca5e90b147553aa5db872967761c7d37
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
filingDate 1980-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c52dd2a9936ca756ae4758636d04984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9dcd687ae6a15264b86fd41d2c8b8ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269518bf7707d7397ef72740950201ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec91cf67352ec04bd96f72223f039381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0274f6ab2fd90c12f9d813b39daf2fa4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c1b93949dddf143040f0384a72e9f3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68e46dc0a598d49583a71149d31691fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e3da31b200130af3768cc67a22c466
publicationDate 1981-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S56169676-A
titleOfInvention Novel substituted benzylidene hydrazinophthalazine derivative
abstract NEW MATERIAL:A substituted benzylidene hydrazinophthalazine derivative expressed by formula I [A is substituted aminohydroxypropoxy of formula II (R is H, alkyl or ≤10C aralkyl which may be substituted by up to 2 methoxyl groups), and group A is substituted at the o-, m- or p-position to the phthalazinylhydrazonomethyl group; B is H, Br or metoxyl; however, B is H when A is substituted at the o- or m-position] and a salt thereof. n EXAMPLE: 1- [ 4- ( 3-Iso-propylamino-2-hydroxypropoxy ) benzylidene hydrazino ] phthalazine. n USE: A hypotensive agent having blocking action on the sympathetic β-receptor and vasodilator action. n PROCESS: A compound expressed by formula II (Q is formula IV, etc.) is reacted with a primary amine expressed by the formula R-NH 2 . n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005526759-A
priorityDate 1980-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236512243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236512221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10317579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236503383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136023165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236503836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70561734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12133079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136473211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236503388

Total number of triples: 33.